Global Burden of Disease 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223–49.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75:1334–57.
CAS PubMed Article Google Scholar
Cuspidi C, Tadic M, Grassi G. How to unmask masked hypertension: The role of office aortic blood pressure. Hypertens Res. 2021;44:256–8.
Antza C, Vazakidis P, Doundoulakis I, Bouras E, Haidich AB, Stabouli S, et al. Masked and white coat hypertension, the double trouble of large arteries: a systematic review and meta-analysis. J Clin Hypertens. 2020;22:802–11.
Cuspidi C, Facchetti R, Quarti-Trevano F, Sala C, Tadic M, Grassi G, et al. Incident left ventricular hypertrophy in masked hypertension. Hypertension. 2019;74:56–62.
CAS PubMed Article Google Scholar
Sekoba NP, Kruger R, Labuschagne P, Schutte AE. Left ventricular mass independently associates with masked hypertension in young healthy adults: The African-PREDICT study. J Hypertens. 2018;36:1689–96.
CAS PubMed Article Google Scholar
Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol. 2015;66:2159–69.
PubMed PubMed Central Article Google Scholar
Thompson JE, Smith W, Ware LJ, C MCM, van Rooyen JM, Huisman HW, et al. Masked hypertension and its associated cardiovascular risk in young individuals: The African-PREDICT study. Hypertens Res. 2016;39:158–65.
CAS PubMed Article Google Scholar
Palla M, Saber H, Konda S, Briasoulis A. Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis. Integr Blood Press Control. 2018;11:11–24.
CAS PubMed PubMed Central Article Google Scholar
Zhang D-Y, Guo Q-H, An D-W, Li Y, Wang J-G. A comparative meta-analysis of prospective observational studies on masked hypertension and masked uncontrolled hypertension defined by ambulatory and home blood pressure. J Hypertens. 2019;37:1775–85.
CAS PubMed Article Google Scholar
Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014;63:675–82.
CAS PubMed Article Google Scholar
Harrison DG, Coffman TM, Wilcox CS. Pathophysiology of hypertension: The Mosaic Theory and beyond. Circ Res. 2021;128:847–63.
CAS PubMed PubMed Central Article Google Scholar
Tzoulaki I, Iliou A, Mikros E, Elliott P. An overview of metabolic phenotyping in blood pressure research. Curr Hypertens Rep. 2018;20:78 https://doi.org/10.1007/s11906-018-0877-8.
Article PubMed PubMed Central Google Scholar
Chakraborty S, Mandal J, Yang T, Cheng X, Yeo J-Y, McCarthy CG, et al. Metabolites and hypertension: Insights into hypertension as a metabolic disorder. Hypertension. 2020;75:1386–96.
CAS PubMed Article Google Scholar
McGarrah RW, Crown SB, Zhang G-F, Shah SH, Newgard CB. Cardiovascular metabolomics. Circ Res. 2018;122:1238–58.
CAS PubMed PubMed Central Article Google Scholar
Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311–26.
CAS PubMed PubMed Central Article Google Scholar
Guasch-Ferré M, Hruby A, Toledo E, Clish CB, Martínez-González MA, Salas-Salvadó J, et al. Metabolomics in prediabetes and diabetes: A systematic review and meta-analysis. Diabetes Care. 2016;39:833–46.
PubMed PubMed Central Article CAS Google Scholar
Schutte AE, Gona PN, Delles C, Uys AS, Burger A, Mels CM, et al. The African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension (African-PREDICT): Design, recruitment and initial examination. Eur J Prev Cardiol. 2019;26:458–70.
PubMed PubMed Central Article Google Scholar
Malan L, Hamer M, Frasure-Smith N, Steyn HS, Malan NT. Cohort Profile: Sympathetic activity and Ambulatory Blood Pressure in Africans (SABPA) prospective cohort study. Int J Epidemiol. 2014;44:1814–22.
PubMed PubMed Central Article Google Scholar
Mels CMC, Schutte AE, Erasmus E, Huisman HW, Schutte R, Fourie CMT, et al. l-Carnitine and long-chain acylcarnitines are positively correlated with ambulatory blood pressure in humans: The SABPA Study. Lipids. 2013;48:63–73.
CAS PubMed Article Google Scholar
Ekoru K, Murphy G, Young E, Delisle H, Jerome C, Assah F, et al. Deriving an optimal threshold of waist circumference for detecting cardiometabolic risk in sub-Saharan Africa. Int J Obes. 2018;42:487–94.
Yang W-Y, Thijs L, Zhang Z-Y, Asayama K, Boggia J, Hansen TW, et al. Evidence-based proposal for the number of ambulatory readings required for assessing blood pressure level in research settings: an analysis of the IDACO database. Blood Press. 2018;27:341–50.
De Beer D, Mels CM, Schutte AE, Louw R, Delles C, Kruger RJN, et al. Left ventricular mass and urinary metabolomics in young black and white adults: the African-PREDICT study. Nutr Metab Cardiovasc Dis. 2020;30:2051–62.
PubMed Article CAS Google Scholar
Mels CM, Delles C, Louw R, Schutte AEJJoh. Central systolic pressure and a nonessential amino acid metabolomics profile: the African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension. J Hypertens. 2019;37:1157–66.
CAS PubMed PubMed Central Article Google Scholar
van Deventer CA, Lindeque JZ, van Rensburg PJ, Malan L, van der Westhuizen FH, Louw R. Use of metabolomics to elucidate the metabolic perturbation associated with hypertension in a black South African male cohort: the SABPA study. J Am Soc Hypertens. 2015;9:104–14.
Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N. Eng J Med. 2010;362:800–11.
Minkler PE, Stoll MS, Ingalls ST, Kerner J, Hoppel CL. Validated method for the quantification of free and total carnitine, butyrobetaine, and acylcarnitines in biological samples. Anal Chem. 2015;87:8994–9001.
CAS PubMed Article Google Scholar
Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012;15:606–14.
CAS PubMed PubMed Central Article Google Scholar
Wu G. Amino acids: Metabolism, functions, and nutrition. Amino acids. 2009;37:1–17.
PubMed Article CAS Google Scholar
Zhang Z-Y, Monleon D, Verhamme P, Staessen JA. Branched-chain amino acids as critical switches in health and disease. Hypertension. 2018;72:1012–22.
CAS PubMed Article Google Scholar
van Vliet S, Burd NA, van Loon LJ. The skeletal muscle anabolic response to plant- versus animal-based protein consumption. J Nutr. 2015;145:1981–91.
Merz B, Frommherz L, Rist MJ, Kulling SE, Bub A, Watzl B. Dietary pattern and plasma BCAA-variations in healthy men and women-results from the KarMeN Study. Nutrients. 2018;10:623 https://doi.org/10.3390/nu10050623.
CAS Article PubMed Central Google Scholar
Ye Z, Wang S, Zhang C, Zhao Y. Coordinated modulation of energy metabolism and inflammation by branched-chain amino acids and fatty acids. Front Endocrinol. 2020;11:617 https://doi.org/10.3389/fendo.2020.00617.
Flores-Guerrero JL, Groothof D, Connelly MA, Otvos JD, Bakker SJL, Dullaart RPF. Concentration of branched-chain amino acids is a strong risk marker for incident hypertension. Hypertension. 2019;74:1428–35.
CAS PubMed Article Google Scholar
Tobias DK, Lawler PR, Harada PH, Demler OV, Ridker PM, Manson JE, et al. Circulating branched-chain amino acids and incident cardiovascular disease in a prospective cohort of US women. Circ Genom Precis Med. 2018;11:e002157–e002157.
CAS PubMed PubMed Central Article Google Scholar
Ruiz-Canela M, Toledo E, Clish CB, Hruby A, Liang L, Salas-Salvadó J, et al. Plasma branched-chain amino acids and incident cardiovascular disease in the PREDIMED Trial. Clin Chem. 2016;62:582–92.
CAS PubMed PubMed Central Article Google Scholar
Sciarretta S, Volpe M, Sadoshima J. Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res. 2014;114:549–64.
CAS PubMed PubMed Central Article Google Scholar
Latimer MN, Sonkar R, Mia S, Frayne IR, Carter KJ, Johnson CA, et al. Branched chain amino acids selectively promote cardiac growth at the end of the awake period. J Mol Cell Cardiol. 2021;157:31–44.
留言 (0)